508 related articles for article (PubMed ID: 19273706)
1. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.
Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR
J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706
[TBL] [Abstract][Full Text] [Related]
2. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
3. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States.
Bilimoria KY; Balch CM; Bentrem DJ; Talamonti MS; Ko CY; Lange JR; Winchester DP; Wayne JD
Ann Surg Oncol; 2008 Jun; 15(6):1566-76. PubMed ID: 18414952
[TBL] [Abstract][Full Text] [Related]
4. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy.
Cormier JN; Xing Y; Ding M; Lee JE; Mansfield PF; Gershenwald JE; Ross MI; Du XL
J Clin Oncol; 2005 Sep; 23(25):6054-62. PubMed ID: 16135473
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing the use of sentinel lymph node biopsy in the Netherlands.
Huismans AM; Niebling MG; Wevers KP; Schuurman MS; Hoekstra HJ
Ann Surg Oncol; 2014 Oct; 21(11):3395-400. PubMed ID: 24819123
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
7. Melanoma in children and the use of sentinel lymph node biopsy.
Bütter A; Hui T; Chapdelaine J; Beaunoyer M; Flageole H; Bouchard S
J Pediatr Surg; 2005 May; 40(5):797-800. PubMed ID: 15937817
[TBL] [Abstract][Full Text] [Related]
8. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
[TBL] [Abstract][Full Text] [Related]
9. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
Hieken TJ; Velasco JM
Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
[TBL] [Abstract][Full Text] [Related]
11. The prognostic importance of sentinel lymph node biopsy in thin melanoma.
Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ
Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753
[TBL] [Abstract][Full Text] [Related]
12. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
[TBL] [Abstract][Full Text] [Related]
13. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.
Dalal KM; Patel A; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2007 Jun; 14(6):1934-42. PubMed ID: 17406951
[TBL] [Abstract][Full Text] [Related]
14. Compliance with guidelines in the surgical management of cutaneous melanoma across the USA.
Wasif N; Gray RJ; Bagaria SP; Pockaj BA
Melanoma Res; 2013 Aug; 23(4):276-82. PubMed ID: 23695440
[TBL] [Abstract][Full Text] [Related]
15. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
Scott JD; McKinley BP; Bishop A; Trocha SD
Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
[TBL] [Abstract][Full Text] [Related]
17. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience.
Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC
Breast J; 2008; 14(5):421-7. PubMed ID: 18657140
[TBL] [Abstract][Full Text] [Related]
18. False-negative sentinel lymph node biopsy in head and neck melanoma.
Miller MW; Vetto JT; Monroe MM; Weerasinghe R; Andersen PE; Gross ND
Otolaryngol Head Neck Surg; 2011 Oct; 145(4):606-11. PubMed ID: 21659495
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in the use of sentinel lymph node biopsy for melanoma: a potential quality measure.
Lane K; Kempf A; Magno C; Lane J; Butler J; Hsiang D; Greenfield S; Jakowatz J
Am Surg; 2008 Oct; 74(10):981-4. PubMed ID: 18942627
[TBL] [Abstract][Full Text] [Related]
20. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
